Skip to main
RXST
RXST logo

RxSight (RXST) Stock Forecast & Price Target

RxSight (RXST) Analyst Ratings

Based on 9 analyst ratings
Hold
Strong Buy 11%
Buy 0%
Hold 67%
Sell 22%
Strong Sell 0%

Bulls say

RxSight Inc. is positioned for sustained double-digit growth due to increasing utilization rates within its expanding light adjustable lens (LDD) installed base. The company's financial outlook benefits from potential upside drivers, including accelerated growth in the LDD installed base, higher laser-assisted lenses (LAL) volumes, and improved profit margins. Furthermore, as LALs constitute a larger portion of total revenue, cash burn is expected to decrease, enhancing overall financial stability.

Bears say

RxSight Inc faces significant risks that could adversely impact its financial outlook, including limited adoption of its intraocular lens technology due to the necessity for additional capital equipment. Furthermore, the company is confronting challenges related to disappointing commercial execution and increased competition within the intraocular lens market. As a consequence, projected revenues for 2025 and 2026 have been revised downward to $164 million and $205 million, respectively, reflecting a loss of confidence in future performance.

RxSight (RXST) has been analyzed by 9 analysts, with a consensus rating of Hold. 11% of analysts recommend a Strong Buy, 0% recommend Buy, 67% suggest Holding, 22% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of RxSight and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About RxSight (RXST) Forecast

Analysts have given RxSight (RXST) a Hold based on their latest research and market trends.

According to 9 analysts, RxSight (RXST) has a Hold consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

RxSight (RXST)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.